These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6981441)

  • 21. Synergistic effect of 3'-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo.
    Svendsen KR; Overgaard-Hansen K; Frederiksen S
    Cancer Chemother Pharmacol; 1988; 21(1):35-9. PubMed ID: 3257721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of growth-inhibitory activity of 9-beta-D-arabinofuranosyladenine by 2'-deoxycoformycin in human cultured cell lines derived from leukemias and lymphomas.
    Kuroki Y; Shimoyama M; Inaba S; Hirose M
    Jpn J Cancer Res; 1989 May; 80(5):482-9. PubMed ID: 2502523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of deoxyadenosine plus deoxycoformycin on replicative and repair synthesis of DNA in human lymphoblasts and isolated nuclei.
    Matsumoto SS; Yu J; Yu AL
    J Biol Chem; 1988 May; 263(15):7153-8. PubMed ID: 3259231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of deoxycoformycin on bone marrow cells treated with adenosine and deoxyadenosine and hemopoietic growth factors.
    Fabian I; Williams Z
    Hum Immunol; 1988 Feb; 21(2):81-7. PubMed ID: 3259223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2'-deoxycoformycin. A new anticancer agent.
    Poster DS; Penta JS; Bruno S; Macdonald JS
    Cancer Clin Trials; 1981; 4(2):209-13. PubMed ID: 7018725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
    Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
    Kefford RF; Fox RM
    Br J Haematol; 1982 Apr; 50(4):627-36. PubMed ID: 6978147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
    Smith CM; Henderson JF
    Biochem Pharmacol; 1982 Apr; 31(8):1545-51. PubMed ID: 6980005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of ADA inhibition on B cell differentiation in the rat.
    Barton RW
    Adv Exp Med Biol; 1986; 195 Pt A():525-9. PubMed ID: 3524140
    [No Abstract]   [Full Text] [Related]  

  • 30. Biochemical mechanisms of deoxycoformycin toxicity in chronic leukemias.
    Ganeshaguru K; Ho AD; Piga A; Catovsky D; Hoffbrand AV
    Leuk Res; 1987; 11(10):941-5. PubMed ID: 3500370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitor of 2', 5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
    Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H
    Adv Exp Med Biol; 1986; 195 Pt B():683-7. PubMed ID: 3490130
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
    Ratech H; Kim J; Asofsky R; Thorbecke GJ; Hirschhorn R
    J Immunol; 1984 Jun; 132(6):3077-84. PubMed ID: 6202772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitor of 2',5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
    Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H
    Biochem Biophys Res Commun; 1985 Mar; 127(3):1019-25. PubMed ID: 3872657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
    Ratech H; Thorbecke GJ; Hirschhorn R
    Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339
    [No Abstract]   [Full Text] [Related]  

  • 36. Resistance of pokeweed mitogen-stimulated B cells to inhibition by deoxyadenosine.
    Hayward AR
    Clin Exp Immunol; 1980 Jul; 41(1):141-9. PubMed ID: 6969149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of nucleosides and deoxycoformycin on adenosine and deoxyadenosine inhibition of human lymphocyte activation.
    Uberti J; Lightbody JJ; Johnson RM
    J Immunol; 1979 Jul; 123(1):189-93. PubMed ID: 312874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATP depletion as a consequence of adenosine deaminase inhibition in man.
    Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specificity of 2'-deoxycoformycin inhibition of adenosine metabolism in intact human skin fibroblasts.
    Holland MJ
    Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):311-24. PubMed ID: 3486439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific immunosuppressive effects of constant infusion of 2'-deoxycoformycin.
    Trotta PP; Tedde A; Ikehara S; Pahwa R; Good RA; Balis ME
    Cancer Res; 1981 Jun; 41(6):2189-96. PubMed ID: 6972248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.